Lower Use of Epidurals Seen Among Pregnant Women Facing Social Inequities

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Feb. 9, 2024 -- Pregnant women facing less socioeconomic opportunity experience lower use of epidurals, particularly Black women, according to a study published online Feb. 1 in Obstetrics & Gynecology.

Jean Guglielminotti, M.D., Ph.D., from Columbia University Vagelos College of Physicians and Surgeons in New York City, and colleagues examined the association between structural racism and labor neuraxial analgesia use. The analysis included data from 1.7 million birth certificates from 2017 (22.8 percent for Black women). A structural racism index was calculated by the county of the delivery hospital as the mean of three Black–White inequity ratios (ratios for lower education, unemployment, and incarceration in jails).

The researchers found that the labor neuraxial analgesia rate was 77.2 percent for Black women in the first tercile of the racism index, 74.7 percent in the second tercile, and 72.4 percent in the third tercile, while the rates were 80.4, 78.2, and 78.2 percent, respectively, for White women. For Black women, the second and third tercile were associated with decreased adjusted odds of receiving neuraxial analgesia (18.4 and 28.3 percent, respectively) compared with the first tercile of the racism index. For White women, the decreases were 13.4 and 15.6 percent in the second and third tercile, respectively. There was a significant difference in the odds of neuraxial analgesia between Black and White women for the second and third terciles.

"Social inequity and racism could be significant contributors to racial and ethnic disparities in labor neuraxial analgesia use," Guglielminotti said in a statement. "Racism -- including structural, institutional, and interpersonal racism -- is suggested as a root cause of racial and ethnic disparities in perinatal care access and utilization in the United States."

One author disclosed ties to the bioscience industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-02-10 00:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords